The Therapeutic Goods Administration (TGA) has approved Wegovy, a daily weight loss tablet, for use in Australia. This approval marks the first time an oral GLP-1 receptor agonist has been cleared by the TGA. However, the product will not be available until the TGA reviews and confirms that its packaging and production processes meet regulatory standards.
TGA clears weight loss tablets for use in Australia (this article)